Member Info for Flippineck

Two RNS’s in 2 days, plenty of buyers today and the share price is rising.

The lecturer in chief seems a bit rattled and wants to change the agenda. Nothing new there.

Wyn, time for you and Viking to get aboard the longboat and head to Harland and Wolff.

They may be able to keep you afloat a little longer so you can find richer pickings.

In case it is of interest the 80k unknown trade was mine - a buy.

Wyn. Unless you work at Avacta or sit on the Board you have absolutely no idea what discussions or offers may have been made. You constantly tell us “ we have no idea what’s going on”.

Own up and admit you cannot back up your statement.

Wyn - how do you know BP haven’t made any offer?

Not sure about pyrrhic ( had to check the spelling!) but Ice is correct in the sense that statements have been made as though they are facts whereas, in fact, they are opinions only.

None of us know what discussions may be taking place but Avacta do. Only they can decide how best to make the repayment.

I believe Pascal Soriot, the French CEO of AZ, has achieved success by being prepared to take risks.

Just the sort of person who, if interested, may be prepared to make an early doors offer.

Spot on B2HS2L.

Better and cheaper. What’s not to like!

Hi LDA. I believe your questions are valid but feel they should be addressed to the company directly. I doubt they trawl through all the posts on here.

Good luck with you investments.

Touk, I have not attempted to check back through your posts but I believe you had expressed concern about half life for AVA 6000. The Spotlight series had already made it clear there was no problem with half life with doxorubicin in this respect.

Obviously other warheads may have issues with half life (which they can now adjust) but there has never been a problem with AVA6000 to the best of my knowledge.

We are fortunate to have some posters, both on here and on twitter, who have a deep understanding of the science here.

I am not an expert on the science, neither am I an expert on body language. Having said that I feel there is a quiet confidence from CC and her team in what they have. They seem relaxed.

Of course none of us know every thing going on behind the scenes and nor should we. We have no idea what conversations with big Pharma may have taken place.

I feel we are close to a pivotal point. You either believe in Avacta or you don’t. The bickering on here is largely pointless. I feel this is the year.

GLA

Your question wasn’t chosen because everybody, except you, knew the answer. Why waste time on that when it has been fully explained in Spotlight series.

Keep wondering about it though - or swat up!

AVA!

Exactly. Francis, VP Chemistry said

“With dox the payload is cleared quite slowly. No need to keep it longer for ABA 6000.

With other drugs they can, if need be, adjust half life. So half life isn’t an issue.

It’s great news. Anybody keeping up with RNS’s and the Spotlight presentations should have a good appreciation of what we have and where we are going.

Those who “pop in” from time to time to give their views sound like they may have a bit of catching up to do. Just my perception of course.

GLA.

Viking, if you truly believe in what you say then I assume you will now sell any shares you hold and buy back in the 20’s.

Very best of luck with that.

Can’t even spell “seems”!

Don’t be so hard on yourself and Johno!

Looking good. Let’s just hope Trump doesn’t hear what we may be sitting on!

More than you hold too!!!